1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Active Wound Care Market
4. Market Overview
    4.1. Introduction
        4.1.1. Market Definition
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Active Wound Care Market Analysis and Forecast, 2017–2031
        4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
    5.1. Global Active Wound Care Market: Key Success Factors of Top Companies
    5.2. Regulatory Scenario
    5.3. Porter’s Five Forces Analysis
    5.4. COVID-19 Pandemic impact Analysis
6. Global Active Wound Care Market Analysis and Forecast, By Product Type
    6.1. Introduction & Definition
    6.2. Key Findings / Developments
    6.3. Market Value Forecast, by Product Type, 2017–2031
        6.3.1. Artificial Skin Substitutes
        6.3.2. Autografts
        6.3.3. Growth Factors
    6.4. Market Attractiveness Analysis, By Product Type
7. Global Active Wound Care Market Analysis and Forecast, By Application
    7.1. Introduction & Definition
    7.2. Key Findings / Developments
    7.3. Market Value Forecast, by Application, 2017–2031
        7.3.1. Chronic Wound
        7.3.2. Acute Wound
    7.4. Market Attractiveness Analysis, By Application
8. Global Active Wound Care Market Analysis and Forecast, By End-user
    8.1. Introduction & Definition
    8.2. Key Findings / Developments
    8.3. Market Value Forecast, by End-user, 2017–2031
        8.3.1. Hospitals
        8.3.2. Clinics
        8.3.3. Others
    8.4. Market Attractiveness Analysis, By End-user
9. Global Active Wound Care Market Analysis and Forecast, By Region
    9.1. Key Findings
    9.2. Market Value Forecast, by Region
        9.2.1. North America
        9.2.2. Europe
        9.2.3. Asia Pacific
        9.2.4. Latin America
        9.2.5. Middle East & Africa
    9.3. Market Attractiveness Analysis, By Region
10. North America Active Wound Care Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Key Findings
    10.2. Market Value Forecast, by Product Type, 2017–2031
        10.2.1. Artificial Skin Substitutes
        10.2.2. Autografts
        10.2.3. Growth Factors
    10.3. Market Value Forecast, by Application, 2017–2031
        10.3.1. Chronic Wound
        10.3.2. Acute Wound
    10.4. Market Value Forecast, by End-user, 2017–2031
        10.4.1. Hospitals
        10.4.2. Clinics
        10.4.3. Others
    10.5. Market Value Forecast, by Country, 2017–2031
        10.5.1. U.S.
        10.5.2. Canada
    10.6. Market Attractiveness Analysis
        10.6.1. By Product Type
        10.6.2. By Application
        10.6.3. By End-user
        10.6.4. By Country
11. Europe Active Wound Care Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Product Type, 2017–2031
        11.2.1. Artificial Skin Substitutes
        11.2.2. Autografts
        11.2.3. Growth Factors
    11.3. Market Value Forecast, by Application, 2017–2031
        11.3.1. Chronic Wound
        11.3.2. Acute Wound
    11.4. Market Value Forecast, by End-user, 2017–2031
        11.4.1. Hospitals
        11.4.2. Clinics
        11.4.3. Others
    11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        11.5.1. Germany
        11.5.2. U.K.
        11.5.3. France
        11.5.4. Italy
        11.5.5. Spain
        11.5.6. Rest of Europe
    11.6. Market Attractiveness Analysis
        11.6.1. By Product Type
        11.6.2. By Application
        11.6.3. By End-user
        11.6.4. By Country/Sub-region
12. Asia Pacific Active Wound Care Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Product Type, 2017–2031
        12.2.1. Artificial Skin Substitutes
        12.2.2. Autografts
        12.2.3. Growth Factors
    12.3. Market Value Forecast, by Application, 2017–2031
        12.3.1. Chronic Wound
        12.3.2. Acute Wound
    12.4. Market Value Forecast, by End-user, 2017–2031
        12.4.1. Hospitals
        12.4.2. Clinics
        12.4.3. Others
    12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        12.5.1. China
        12.5.2. Japan
        12.5.3. India
        12.5.4. Australia & New Zealand
        12.5.5. Rest of Asia Pacific
    12.6. Market Attractiveness Analysis
        12.6.1. By Product Type
        12.6.2. By Application
        12.6.3. By End-user
        12.6.4. By Country/Sub-region
13. Latin America Active Wound Care Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Product Type, 2017–2031
        13.2.1. Artificial Skin Substitutes
        13.2.2. Autografts
        13.2.3. Growth Factors
    13.3. Market Value Forecast, by Application, 2017–2031
        13.3.1. Chronic Wound
        13.3.2. Acute Wound
    13.4. Market Value Forecast, by End-user, 2017–2031
        13.4.1. Hospitals
        13.4.2. Clinics
        13.4.3. Others
    13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        13.5.1. Brazil
        13.5.2. Mexico
        13.5.3. Rest of Latin America
    13.6. Market Attractiveness Analysis
        13.6.1. By Product Type
        13.6.2. By Application
        13.6.3. By End-user
        13.6.4. By Country/Sub-region
14. Middle East & Africa Active Wound Care Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast, by Product Type, 2017–2031
        14.2.1. Artificial Skin Substitutes
        14.2.2. Autografts
        14.2.3. Growth Factors
    14.3. Market Value Forecast, by Application, 2017–2031
        14.3.1. Chronic Wound
        14.3.2. Acute Wound
    14.4. Market Value Forecast, by End-user, 2017–2031
        14.4.1. Hospitals
        14.4.2. Clinics
        14.4.3. Others
    14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        14.5.1. GCC Countries
        14.5.2. South Africa
        14.5.3. Rest of MEA
    14.6. Market Attractiveness Analysis
        14.6.1. By Product Type
        14.6.2. By Application
        14.6.3. By End-user
        14.6.4. By Country/Sub-region
15. Competition Landscape
    15.1. Market Player – Competition Matrix (by tier and size of companies)
    15.2. Market Share Analysis, by Company, 2022
    15.3. Company Profiles
        15.3.1. 3M Company
            15.3.1.1. Company Overview
            15.3.1.2. Financial Overview
            15.3.1.3. Product Portfolio
            15.3.1.4. Business Strategies
            15.3.1.5. Recent Developments
        15.3.2. Smith & Nephew
            15.3.2.1. Company Overview
            15.3.2.2. Financial Overview
            15.3.2.3. Product Portfolio
            15.3.2.4. Business Strategies
            15.3.2.5. Recent Developments
        15.3.3. Mölnlycke Health Care
            15.3.3.1. Company Overview
            15.3.3.2. Financial Overview
            15.3.3.3. Product Portfolio
            15.3.3.4. Business Strategies
            15.3.3.5. Recent Developments
        15.3.4. Johnson & Johnson Services
            15.3.4.1. Company Overview
            15.3.4.2. Financial Overview
            15.3.4.3. Product Portfolio
            15.3.4.4. Business Strategies
            15.3.4.5. Recent Developments
        15.3.5. Convatec Group plc
            15.3.5.1. Company Overview
            15.3.5.2. Financial Overview
            15.3.5.3. Product Portfolio
            15.3.5.4. Business Strategies
            15.3.5.5. Recent Developments
        15.3.6. Integra LifeSciences
            15.3.6.1. Company Overview
            15.3.6.2. Financial Overview
            15.3.6.3. Product Portfolio
            15.3.6.4. Business Strategies
            15.3.6.5. Recent Developments
        15.3.7. Paul Hartmann AG
            15.3.7.1. Company Overview
            15.3.7.2. Financial Overview
            15.3.7.3. Product Portfolio
            15.3.7.4. Business Strategies
            15.3.7.5. Recent Developments
        15.3.8. Tissue Regenix
            15.3.8.1. Company Overview
            15.3.8.2. Financial Overview
            15.3.8.3. Product Portfolio
            15.3.8.4. Business Strategies
            15.3.8.5. Recent Developments
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


 
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			